PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Endocrinology and Metabolism10.3803/enm.2015.30.3.2722015303272Efficacy of a Once-Monthly Pill Containing Ibandronate and Cholecalciferol on the Levels of 25-Hydroxyvitamin D and Bone Markers in Postmenopausal Women with OsteoporosisIn-Jin Cho, Ho-Yeon Chung, Sung-Woon Kim, Jae-Won Lee, Tae-Won Lee, Hye-Soon Kim, Sin-Gon Kim, Han Seok Choi, Sung-Hee Choi, Chan Soo Shin, Ki-Won Oh, Yong-Ki Min, Jung-Min Koh, Yumie Rhee, Dong-Won Byun, Yoon-Sok Chung, Jeong Hyun Park, Dong Jin Chung, Minho Shong, Eun-Gyoung Hong, Chang Beom Lee, Ki Hyun Baek, Moo-Il Kanghttps://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2015.30.3.272, https://synapse.koreamed.org/pdf/10.3803/EnM.2015.30.3.272, http://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2015.30.3.272
Maturitas10.1016/j.maturitas.2017.03.1422017100158A monthly combined agent of ibandronate and cholecalciferol is effective in bone metabolism but not in muscle strength and bone mineral density in Korean postmenopausal women with osteoporosisSang Ho Yoonhttps://api.elsevier.com/content/article/PII:S0378512217302888?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0378512217302888?httpAccept=text/plain
International Journal of Rheumatic Diseases10.1111/j.1756-185x.2009.01413.x2009123216-224Impact of bone marker feedback on adherence to once monthly ibandronate for osteoporosis among Asian postmenopausal women THE BonAdASIA STUDY GROUPhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1756-185X.2009.01413.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1756-185X.2009.01413.x/fullpdf
Yearbook of Endocrinology10.1016/s0084-3741(08)70152-520072007331-333Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE studyB.L. Clarkehttps://api.elsevier.com/content/article/PII:S0084374108701525?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0084374108701525?httpAccept=text/plain
Bone10.1016/j.bone.2009.03.383200944S433Compliance, persistence and patient satisfaction in 150 mg once-monthly oral ibandronate treated patients with postmenopausal osteoporosis — A non-interventional studyH. Börst, D. Felsenberg, J. Glaab, O. Bockhttps://api.elsevier.com/content/article/PII:S8756328209011454?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S8756328209011454?httpAccept=text/plain
Archives of Osteoporosis10.1007/s11657-017-0306-72017121Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal womenAkram Kharroubi, Elias Saba, Riham Smoom, Khaldoun Bader, Hisham Darwishhttp://link.springer.com/article/10.1007/s11657-017-0306-7/fulltext.html, http://link.springer.com/content/pdf/10.1007/s11657-017-0306-7.pdf, http://link.springer.com/content/pdf/10.1007/s11657-017-0306-7.pdf
Endocrine Practice10.1016/s1530-891x(20)44061-320061245Abstract #314: Once-Monthly Ibandronate in Postmenopausal Osteoporosis: Two-Year Efficacy and Safety Data from MOBILEMichael A. Bolognese, Mone Zaidi, Keith E. Friend, E. Michael Lewieckihttps://api.elsevier.com/content/article/PII:S1530891X20440613?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1530891X20440613?httpAccept=text/plain
Clinical Interventions in Aging10.2147/cia.s443952013597Early changes in 25-hydroxyvitamin D levelsand bone markers after monthly risedronatewith cholecalciferol in Korean patients with osteoporosisHoyeon Chung, Koo, Kwon, Kang, Moon, Jin-Young Park, Shin, Yoon, Yoon, Chang, Yoon-Sok Chung, Parkhttps://www.dovepress.com/getfile.php?fileID=16252
Bone10.1016/j.bone.2010.03.00320104661626-1632Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosisKlaus Engelke, Thomas Fuerst, Gorana Dasic, Richard Y. Davies, Harry K. Genanthttps://api.elsevier.com/content/article/PII:S8756328210004941?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S8756328210004941?httpAccept=text/plain
Clinical Therapeutics10.1016/j.clinthera.2006.04.0062006284475-490Once-monthly Ibandronate for postmenopausal Osteoporosis: Review of a new dosing regimenEunice Y. Pyonhttps://api.elsevier.com/content/article/PII:S0149291806000944?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0149291806000944?httpAccept=text/plain